ATH
ALTERITY FPO [ATH]
Healthcare · ASX Small Cap
$0.0080 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical71
Catalyst53
Sentiment50
Fundamental77
Momentum56
Risk Gate35
Get alerts when ATH's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Knocking on the door of resistance — if it punches through, things could get interesting
- On a tear — up 14.3% over the last 5 days
- Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Strong cash runway (14 quarters)
- Moderate P/S ratio (13.1x)
- Strong revenue growth (+75%)
- Near 52-week low (17% of range)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- CANSLIM I: Institutional ownership (19%)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +75% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.72%/day)
- Penny stock risk ($0.008)
- RBA hiking (-3pts)
- Dilution risk: technical breakout with recent capital raise
Risk Signals
- Stochastic is stretched into overbought — could need a breather
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-220%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 27% over the past year
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ATH
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Proposed issue of securities - ATH
NONE Unmarketable Parcel Sale Facility
NONE Alterity to Participate in the Bell Potter Healthcare Summit
Announcement tone +3pts
Recent ASX Announcements
| 2026-03-19 | Proposed issue of securities - ATH |
| 2026-03-12 | Unmarketable Parcel Sale Facility |
| 2026-03-09 | Alterity to Participate in the Bell Potter Healthcare Summit |
| 2026-03-03 | Dr Daniel Claassen as Chief Medical Advisor |
| 2026-02-25 | Half Yearly Report and Accounts PRICE SENSITIVE |
Key Metrics
$87.0M
Market Cap
3.6M
Avg Volume
0.4x
Vol Ratio
$0.01 — $0.02
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-47.0%
ROE
-219.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 76% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | pass | Inst: 19% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #94 of 117 · Sector avg: 46
View all Healthcare signals →Track ATH and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required